Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 9 December

Grady Wulff
December 9, 2022

Closing Bell 8 December

Grady Wulff
December 8, 2022

Morning Bell 8 November

Grady Wulff
December 8, 2022

Morning Bell 6 December

Sophia Mavridis
December 6, 2022

Closing Bell 5 December

Grady Wulff
December 5, 2022

Morning Bell 5 December

Grady Wulff
December 5, 2022

Weekly Wrap 2 December

Sophia Mavridis
December 2, 2022

Morning Bell 2 December

Sophia Mavridis
December 2, 2022

Closing Bell 1 December

Sophia Mavridis
December 1, 2022

Morning Bell 1 December

Sophia Mavridis
December 1, 2022

Closing Bell 30 November

Sophia Mavridis
November 30, 2022